ArticlePediatric cardiology2026
ASD Diameter Indexed to Total Septal Length Outperforms Expert Opinion in Predicting Future Candidacy for Percutaneous ASD Closure.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous device closure is an attractive alternative to surgical closure of secundum atrial septal defects (ASDs) for those with suitable anatomy and size. Early surgery (< 2 years of age) allows for a more feasible "mini sternotomy" technique, while device closure is more commonly performed at an older age. Thus, the ability to predict future device-closure candidacy before 2 years of age is needed. Secundum ASD closures after 3 years of age from 2012 to 2023 at a single center were reviewed (n = 54). "Early" echocardiograms (obtained at 12-24 months of age) and "pre-intervention" echocardiograms (the last echo obtained prior to closure and after 36 months of age) for each patient were independently reviewed by echocardiographers who performed standardized measurements. The catheterization team reviewed the same echocardiograms and made recommendations on device closure candidacy. Reviewers were blinded to the paired echocardiograms and eventual interventions. There was moderate agreement in perceived device candidacy by catheterization team consensus between early and pre-intervention echocardiogram (Cohen's Kappa = 0.56, p < 0.001). In a multivariable model, the ratio of maximum ASD diameter indexed to total septal length (ASD/TSL) between 1 and 2 years of age was strongly predictive of eventual perceived candidacy for device closure (Area Under the Curve = 0.92, sensitivity 89%, specificity 89% at the optimal threshold of 0.46) outperforming expert consensus (sensitivity 81%, specificity of 77%). Patients with ASD/TSL < 0.46 on early echocardiograms are likely to be considered device candidates later in life.
Indexed as
Identifiers
42095916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.